Радость движения. Как физическая активность помогает обрести счастье, смысл, уверенность в себе и преодолеть трудности. Келли МакгонигалЧитать онлайн книгу.
Finn. “Why We Love to Run.” The Guardian, February 5, 2013; https://www.theguardian.com/lifeandstyle/the-running-blog/2013/feb/05/why-we-love-to-run.
32
Robin Christensen et al. “Efficacy and Safety of the Weight-Loss Drug Rimonabant: A Meta-Analysis of Randomised Trials.” The Lancet 370, № 9600 (2007): P1706–1713.
33
Hamilton Morris. “New Frontiers of Sobriety.” Vice, July 31, 2009; https://www.vice.com/en_us/article/kwg8ny/new-frontiers-of-sobriety-984-v16n8.
34
Brooke K. Keeney et al. “Differential Response to a Selective Cannabinoid Receptor Antagonist (SR141716: Rimonabant) in Female Mice from Lines Selectively Bred for High Voluntary Wheel-Running Behaviour.” Behavioural Pharmacology 19, № 8 (2008): 812–820; Sarah Dubreucq et al. “Ventral Tegmental Area Cannabinoid Type-1 Receptors Control Voluntary Exercise Performance.” Biological Psychiatry 73, № 9 (2013): 895–903.
35
Johannes Fuss et al. “A Runner’s High Depends on Cannabinoid Receptors in Mice.” Proceedings of the National Academy of Sciences of the USA 112, № 42 (2015): 13105–13108.
36
Eli Puterman et al. “Physical Activity and Negative Affective Reactivity in Daily Life.” Health Psychology 36, № 12 (2017): 1186–1194.
37
Andreas Ströhle et al. “The Acute Antipanic and Anxiolytic Activity of Aerobic Exercise in Patients with Panic Disorder and Healthy Control Subjects.” Journal of Psychiatric Research 43, № 12 (2009): 1013–1017.
38
Nora D. Volkow, Aidan J. Hampson, and Ruben D. Baler. “Don’t Worry, Be Happy: Endocannabinoids and Cannabis at the Intersection of Stress and Reward.” Annual Review of Pharmacology and Toxicology 57 (2017): 285–308.